HEADER TRANSFERASE 20-SEP-23 8QLS TITLE HUMAN MST3 (STK24) KINASE IN COMPLEX WITH INHIBITOR MR26 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 24; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAMMALIAN STE20-LIKE PROTEIN KINASE 3,MST-3,STE20-LIKE COMPND 5 KINASE MST3; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK24, MST3, STK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SELECTIVE KINASE INHIBITORS, STRUCTURE-GUIDED DRUG DESIGN, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.I.BALOURDAS,M.RAK,S.KNAPP,A.C.JOERGER,STRUCTURAL GENOMICS AUTHOR 2 CONSORTIUM (SGC) REVDAT 1 08-NOV-23 8QLS 0 JRNL AUTH D.I.BALOURDAS,M.RAK,S.KNAPP,A.C.JOERGER JRNL TITL HUMAN MST3 (STK24) KINASE IN COMPLEX WITH INHIBITOR MR26 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.55 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 45277 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.151 REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 2229 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.5500 - 4.0600 0.98 2754 140 0.1424 0.1638 REMARK 3 2 4.0600 - 3.2200 1.00 2747 134 0.1356 0.1657 REMARK 3 3 3.2200 - 2.8100 0.98 2696 147 0.1588 0.1692 REMARK 3 4 2.8100 - 2.5600 0.98 2666 137 0.1588 0.2211 REMARK 3 5 2.5600 - 2.3700 0.99 2688 140 0.1482 0.2093 REMARK 3 6 2.3700 - 2.2300 1.00 2702 155 0.1423 0.1792 REMARK 3 7 2.2300 - 2.1200 1.00 2700 149 0.1443 0.1824 REMARK 3 8 2.1200 - 2.0300 1.00 2703 143 0.1434 0.1938 REMARK 3 9 2.0300 - 1.9500 0.97 2632 137 0.1584 0.2054 REMARK 3 10 1.9500 - 1.8800 0.98 2654 138 0.1730 0.2105 REMARK 3 11 1.8800 - 1.8200 0.99 2648 156 0.1575 0.2088 REMARK 3 12 1.8200 - 1.7700 0.99 2663 154 0.1434 0.1963 REMARK 3 13 1.7700 - 1.7300 0.99 2711 126 0.1482 0.2062 REMARK 3 14 1.7300 - 1.6800 0.99 2693 112 0.1712 0.1732 REMARK 3 15 1.6800 - 1.6500 1.00 2696 135 0.2119 0.2650 REMARK 3 16 1.6500 - 1.6100 0.98 2695 126 0.2849 0.3497 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.178 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.373 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.95 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2253 REMARK 3 ANGLE : 0.943 3041 REMARK 3 CHIRALITY : 0.056 336 REMARK 3 PLANARITY : 0.008 417 REMARK 3 DIHEDRAL : 6.357 341 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8QLS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1292133420. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45283 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.610 REMARK 200 RESOLUTION RANGE LOW (A) : 39.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.03500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.72500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 11 MG/ML MST3 IN 25 REMARK 280 MM HEPES PH 7.5, 200 MM NACL, 0.5 MM TCEP, 5% GLYCEROL) WITH 1 REMARK 280 MM COMPOUND MR26. RESERVOIR SOLUTION: 10% PEG 6000, 0.1 M HEPES REMARK 280 PH 7.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.55450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.38100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.55450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 29.38100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 3 REMARK 465 ARG A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 6 REMARK 465 LEU A 7 REMARK 465 TRP A 8 REMARK 465 GLY A 9 REMARK 465 LEU A 10 REMARK 465 ALA A 11 REMARK 465 LEU A 12 REMARK 465 ASN A 13 REMARK 465 LYS A 14 REMARK 465 ARG A 15 REMARK 465 ARG A 16 REMARK 465 ALA A 17 REMARK 465 THR A 18 REMARK 465 LEU A 19 REMARK 465 PRO A 20 REMARK 465 HIS A 21 REMARK 465 PRO A 22 REMARK 465 GLY A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 GLY A 179 REMARK 465 GLN A 180 REMARK 465 LEU A 181 REMARK 465 THR A 182 REMARK 465 ASP A 183 REMARK 465 THR A 184 REMARK 465 GLN A 185 REMARK 465 ILE A 186 REMARK 465 LYS A 187 REMARK 465 ARG A 188 REMARK 465 ASN A 189 REMARK 465 THR A 190 REMARK 465 PHE A 191 REMARK 465 VAL A 192 REMARK 465 GLY A 193 REMARK 465 HIS A 308 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 LYS A 44 CG CD CE NZ REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 ASP A 74 CG OD1 OD2 REMARK 470 VAL A 177 CG1 CG2 REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 LYS A 282 CD CE NZ REMARK 470 LYS A 284 NZ REMARK 470 LYS A 291 CE NZ REMARK 470 LYS A 292 CE NZ REMARK 470 HIS A 304 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 305 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 39 -145.98 -114.98 REMARK 500 PHE A 47 -2.16 60.93 REMARK 500 ASP A 104 -123.14 45.41 REMARK 500 ARG A 155 -8.77 82.32 REMARK 500 ASP A 156 53.74 -143.43 REMARK 500 LEU A 267 57.74 -95.21 REMARK 500 REMARK 500 REMARK: NULL DBREF 8QLS A 4 301 UNP Q9Y6E0 STK24_HUMAN 4 301 SEQADV 8QLS MET A 3 UNP Q9Y6E0 INITIATING METHIONINE SEQADV 8QLS ALA A 302 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLS HIS A 303 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLS HIS A 304 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLS HIS A 305 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLS HIS A 306 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLS HIS A 307 UNP Q9Y6E0 EXPRESSION TAG SEQADV 8QLS HIS A 308 UNP Q9Y6E0 EXPRESSION TAG SEQRES 1 A 306 MET ARG ALA GLN LEU TRP GLY LEU ALA LEU ASN LYS ARG SEQRES 2 A 306 ARG ALA THR LEU PRO HIS PRO GLY GLY SER THR ASN LEU SEQRES 3 A 306 LYS ALA ASP PRO GLU GLU LEU PHE THR LYS LEU GLU LYS SEQRES 4 A 306 ILE GLY LYS GLY SER PHE GLY GLU VAL PHE LYS GLY ILE SEQRES 5 A 306 ASP ASN ARG THR GLN LYS VAL VAL ALA ILE LYS ILE ILE SEQRES 6 A 306 ASP LEU GLU GLU ALA GLU ASP GLU ILE GLU ASP ILE GLN SEQRES 7 A 306 GLN GLU ILE THR VAL LEU SER GLN CYS ASP SER PRO TYR SEQRES 8 A 306 VAL THR LYS TYR TYR GLY SER TYR LEU LYS ASP THR LYS SEQRES 9 A 306 LEU TRP ILE ILE MET GLU TYR LEU GLY GLY GLY SER ALA SEQRES 10 A 306 LEU ASP LEU LEU GLU PRO GLY PRO LEU ASP GLU THR GLN SEQRES 11 A 306 ILE ALA THR ILE LEU ARG GLU ILE LEU LYS GLY LEU ASP SEQRES 12 A 306 TYR LEU HIS SER GLU LYS LYS ILE HIS ARG ASP ILE LYS SEQRES 13 A 306 ALA ALA ASN VAL LEU LEU SER GLU HIS GLY GLU VAL LYS SEQRES 14 A 306 LEU ALA ASP PHE GLY VAL ALA GLY GLN LEU THR ASP THR SEQRES 15 A 306 GLN ILE LYS ARG ASN THR PHE VAL GLY THR PRO PHE TRP SEQRES 16 A 306 MET ALA PRO GLU VAL ILE LYS GLN SER ALA TYR ASP SER SEQRES 17 A 306 LYS ALA ASP ILE TRP SER LEU GLY ILE THR ALA ILE GLU SEQRES 18 A 306 LEU ALA ARG GLY GLU PRO PRO HIS SER GLU LEU HIS PRO SEQRES 19 A 306 MET LYS VAL LEU PHE LEU ILE PRO LYS ASN ASN PRO PRO SEQRES 20 A 306 THR LEU GLU GLY ASN TYR SER LYS PRO LEU LYS GLU PHE SEQRES 21 A 306 VAL GLU ALA CYS LEU ASN LYS GLU PRO SER PHE ARG PRO SEQRES 22 A 306 THR ALA LYS GLU LEU LEU LYS HIS LYS PHE ILE LEU ARG SEQRES 23 A 306 ASN ALA LYS LYS THR SER TYR LEU THR GLU LEU ILE ASP SEQRES 24 A 306 ALA HIS HIS HIS HIS HIS HIS HET VYH A 401 40 HET EDO A 402 4 HET EDO A 403 4 HET EDO A 404 4 HET EDO A 405 4 HET EDO A 406 4 HET EDO A 407 4 HET EDO A 408 4 HET EDO A 409 4 HET EDO A 410 4 HET EDO A 411 4 HET EDO A 412 4 HETNAM VYH 8-(4-AZANYLBUTYL)-6-[2-CHLORANYL-4-(6-METHYLPYRIDIN-2- HETNAM 2 VYH YL)PHENYL]-2-(3-MORPHOLIN-4-YLPROPYLAMINO)PYRIDO[2,3- HETNAM 3 VYH D]PYRIMIDIN-7-ONE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 VYH C30 H36 CL N7 O2 FORMUL 3 EDO 11(C2 H6 O2) FORMUL 14 HOH *259(H2 O) HELIX 1 AA1 ASP A 31 LEU A 35 1 5 HELIX 2 AA2 GLU A 75 GLN A 88 1 14 HELIX 3 AA3 ALA A 119 LEU A 123 1 5 HELIX 4 AA4 ASP A 129 GLU A 150 1 22 HELIX 5 AA5 LYS A 158 ALA A 160 5 3 HELIX 6 AA6 ALA A 199 LYS A 204 1 6 HELIX 7 AA7 SER A 210 GLY A 227 1 18 HELIX 8 AA8 HIS A 235 ASN A 246 1 12 HELIX 9 AA9 SER A 256 LEU A 267 1 12 HELIX 10 AB1 GLU A 270 ARG A 274 5 5 HELIX 11 AB2 THR A 276 LEU A 281 1 6 HELIX 12 AB3 HIS A 283 ALA A 290 1 8 HELIX 13 AB4 LYS A 292 TYR A 295 5 4 HELIX 14 AB5 LEU A 296 HIS A 307 1 12 SHEET 1 AA1 5 PHE A 36 LYS A 44 0 SHEET 2 AA1 5 GLU A 49 ASP A 55 -1 O LYS A 52 N LEU A 39 SHEET 3 AA1 5 VAL A 61 ASP A 68 -1 O ILE A 64 N PHE A 51 SHEET 4 AA1 5 LYS A 106 GLU A 112 -1 O ILE A 109 N LYS A 65 SHEET 5 AA1 5 TYR A 97 LYS A 103 -1 N TYR A 101 O TRP A 108 SHEET 1 AA2 3 GLY A 117 SER A 118 0 SHEET 2 AA2 3 VAL A 162 LEU A 164 -1 O LEU A 164 N GLY A 117 SHEET 3 AA2 3 VAL A 170 LEU A 172 -1 O LYS A 171 N LEU A 163 CRYST1 99.109 58.762 61.495 90.00 93.06 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010090 0.000000 0.000539 0.00000 SCALE2 0.000000 0.017018 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016285 0.00000